{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:55Z","timestamp":1792147795981,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Huntington's Disease (HD) is a rare autosomal dominant neurodegenerative disorder\ncharacterized by progressive motor dysfunction, psychiatric disturbances, and cognitive decline. An\nexpanded CAG trinucleotide repeat in the Huntingtin (HTT) gene causes it to repeat, leading to the\nproduction of mutant Huntingtin Protein (mHTT), which drives selective neuronal degeneration,\nparticularly in the striatum and cortex. Despite the identification of its genetic basis over three decades\nago, HD remains incurable, with current therapies largely limited to symptomatic management.\nThis review provides a comprehensive overview of emerging pharmacological strategies targeting\nthe underlying molecular and cellular mechanisms of HD, with emphasis on translational insights\nfrom recent and ongoing clinical trials. Key pathogenic processes, including protein aggregation,\ntranscriptional dysregulation, impaired proteostasis, mitochondrial dysfunction, synaptic deficits,\nand chronic neuroinflammation, are discussed to contextualize therapeutic approaches. Genetargeting\nstrategies, including Antisense Oligonucleotides (ASOs), RNA interference (RNAi), and\nsmall-molecule splicing modulators, have demonstrated effective suppression of mutant huntingtin\nexpression and favorable biomarker responses. However, despite robust target engagement, these\nmolecular effects have not consistently translated into sustained clinical benefit, highlighting the\ncomplexity of achieving disease modification in Huntington's disease. Similarly, therapies targeting\nneuroinflammation, autophagy, mitochondrial dysfunction, and synaptic signaling have shown encouraging\npreclinical efficacy but only limited clinical success. The review highlights the critical\nrole of biomarkers, including cerebrospinal fluid mHTT, neurofilament light chain, and imaging\nmarkers, in evaluating therapeutic efficacy, while underscoring the uncertainty in their correlation\nwith long-term clinical outcomes. Persistent challenges in clinical translation emphasize the need for\nprecision-based, stage-specific therapeutic strategies to achieve meaningful disease modification.\nUnlike previous reviews, this article critically integrates recent clinical trial outcomes with translational\nchallenges, biomarker validation, regulatory perspectives, and future precision-medicine strategies,\nproviding a comprehensive overview of the evolving therapeutic landscape for Huntington's\ndisease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115748871503552261008112411","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:31Z","timestamp":1792146331000},"source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in Pharmacological Interventions for Huntington's Disease: Evidence from Clinical Translation"],"prefix":"10.2174","volume":"21","author":[{"given":"Varsha","family":"Raj","sequence":"first","affiliation":[{"name":"Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Gupta","sequence":"additional","affiliation":[{"name":"Guru Nanak College of Pharmaceutical Sciences, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Kumari","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sharda University, Plot No.32,34 knowledged Park- III, Greater Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubha","family":"Gaur","sequence":"additional","affiliation":[{"name":"KIET Deemed to be University, Ghaziabad, U.P., India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Chandra","family":"Sharma","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore 452001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Snehi","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Yadav","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Paramedical Sciences, Dr. Bhimrao Ambedkar University, Agra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-6981","authenticated-orcid":true,"given":"Shivendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871503552261008112411","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259500\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871503552261008112411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:39Z","timestamp":1792146339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259500\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748871503552261008112411","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}